CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: moxifloxacin
Accession: CHEBI:63611
browse the term
Definition: A quinolone that consists of 4-oxo-1,4-dihydroquinoline-3-carboxylic acid bearing a cyclopropyl substituent at position 1, a fluoro substitiuent at position 6, a (4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl group at position 7 and a methoxy substituent at position 8. A member of the fluoroquinolone class of antibacterial agents.
Synonyms: exact_synonym: 1-cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
related_synonym: 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid; Formula=C21H24FN3O4; InChI=1S/C21H24FN3O4/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28)/t11-,16+/m0/s1; InChIKey=FABPRXSRWADJSP-MEDUHNTESA-N; SMILES=[H][C@@]12CCCN[C@]1([H])CN(C2)c1c(F)cc2c(c1OC)n(cc(C(O)=O)c2=O)C1CC1
alt_id: CHEBI:7007
xref: CAS:151096-09-2; DrugBank:DB00218; Drug_Central:1854; KEGG:C07663; KEGG:D08237; LINCS:LSM-5746
xref_mesh: MESH:C104727
xref: Patent:EP550903; Reaxys:8365827; VSDB:2983; Wikipedia:Moxifloxacin
cyclic_relationship: is_conjugate_base_of CHEBI:63699
G
Ifng
interferon gamma
decreases expression
ISO
moxifloxacin results in decreased expression of IFNG protein
CTD
PMID:16006447
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il1b
interleukin 1 beta
decreases secretion
ISO
moxifloxacin results in decreased secretion of IL1B protein
CTD
PMID:16352735
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il4
interleukin 4
decreases expression
ISO
moxifloxacin results in decreased expression of IL4 protein
CTD
PMID:16006447
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity
ISO
moxifloxacin results in decreased activity of KCNH2 protein
CTD
PMID:24052561 PMID:27553911
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Mapk1
mitogen activated protein kinase 1
decreases phosphorylation
ISO
moxifloxacin results in decreased phosphorylation of MAPK1 protein
CTD
PMID:16352735
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
decreases phosphorylation
ISO
moxifloxacin results in decreased phosphorylation of MAPK3 protein
CTD
PMID:16352735
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mmp1
matrix metallopeptidase 1
increases secretion decreases secretion
ISO
Moxifloxacin results in increased secretion of MMP1 protein Moxifloxacin results in decreased secretion of MMP1 protein
CTD
PMID:24890593
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
G
Mmp2
matrix metallopeptidase 2
increases activity increases expression
EXP
Moxifloxacin results in increased activity of MMP2 protein Moxifloxacin results in increased expression of MMP2 mRNA
CTD
PMID:21058936
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mmp3
matrix metallopeptidase 3
decreases secretion increases secretion
ISO
Moxifloxacin results in decreased secretion of MMP3 protein Moxifloxacin results in increased secretion of MMP3 protein
CTD
PMID:24890593
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
G
Mmp9
matrix metallopeptidase 9
decreases secretion increases expression increases activity
ISO EXP
Moxifloxacin results in decreased secretion of MMP9 protein Moxifloxacin results in increased expression of MMP9 mRNA Moxifloxacin results in increased activity of MMP9 protein
CTD
PMID:21058936 PMID:24890593
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Pon1
paraoxonase 1
decreases activity
ISO
Moxifloxacin results in decreased activity of PON1 protein
CTD
PMID:31581362
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
G
Rela
RELA proto-oncogene, NF-kB subunit
decreases expression
ISO
moxifloxacin results in decreased expression of RELA protein
CTD
PMID:16352735
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Tnf
tumor necrosis factor
decreases secretion
ISO
moxifloxacin results in decreased secretion of TNF protein
CTD
PMID:16352735
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Top1
DNA topoisomerase I
multiple interactions
ISO
[moxifloxacin co-treated with Camptothecin] results in decreased activity of TOP1 protein
CTD
PMID:18191106
NCBI chr 3:149,293,469...149,376,618
Ensembl chr 3:149,293,403...149,376,623
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
increases glucuronidation
ISO
UGT1A1 protein results in increased glucuronidation of moxifloxacin
CTD
PMID:15769885
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a2
UDP glucuronosyltransferase 1 family, polypeptide A2
increases glucuronidation
ISO
UGT1A3 protein results in increased glucuronidation of moxifloxacin
CTD
PMID:15769885
NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a9
UDP glucuronosyltransferase family 1 member A9
increases glucuronidation
ISO
UGT1A9 protein results in increased glucuronidation of moxifloxacin
CTD
PMID:15769885
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all